Financial advisory firm Lazard (NYSE: LAZ) fell short of the market’s revenue expectations in Q3 2026, but sales rose 11% year on year to $804.6 million. Its non-GAAP profit of $0.36 per share was 13% below analysts’ consensus estimates.

Is now the time to buy LAZ? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Lazard’s third quarter showed notable revenue growth, but results missed Wall Street’s expectations for both sales and non-GAAP profits. Management attributed the year-over-year improvement to growing client activity and continued investments in their advisory and asset management businesses. CEO Peter Orszag highlighted record third quarter revenues in both the Americas and the U.K. and emphasized that recent investments in hiring and platform expansion are starting to deliver tangible results. Orszag also cited strong forward indicators, including a robust pipeline of announced deals and increased conflict clearances, particularly for larger transactions.

Looking ahead, management expects the integration of Campbell Lutyens and the launch of Lazard CL to significantly expand the firm’s private capital advisory business. Orszag stated that the combined platform will “create the leading private capital advisory platform globally” and projected the new business will generate around $500 million in revenue and be accretive to earnings in 2027. On the asset management side, Orszag and Chief Investment Officer Chris Hogbin pointed to continued product development—including new ETFs and fixed income strategies—and a focus on operating leverage as drivers of future growth. However, management acknowledged that uncertainties in private equity deal activity and macroeconomic headwinds could influence the pace of improvement.

Key insights from management’s remarks

Management pointed to several key operational initiatives and market dynamics driving the quarter’s results and outlined strategic priorities that may shape future performance.

• Advisory business momentum: Recent investments in managing directors (MDs) across key sectors—healthcare, technology, industrials—produced record revenues in the Americas and U.K., with client activity robust despite broader market uncertainty. Management noted that their pipeline for large transactions is the strongest in over a decade, supported by a 30% increase in conflict clearances and continued leadership in announced deal league tables.
• Campbell Lutyens acquisition: The firm is set to close its acquisition of Campbell Lutyens and launch Lazard CL, combining private capital advisory with existing M&A and restructuring capabilities. Management believes this will provide a leading global platform for primary fundraising, secondary advisory, and GP capital advisory, with early synergies already visible in vendor and IT integration.
• Asset management platform expansion: Asset management saw growth in management fees and record inflows, attributed to focused sales efforts and improved investment performance. New products, like the IDEQ quant ETF and upcoming fixed income ETFs, are expected to broaden the firm’s offering and attract new mandates.
• Expense discipline and compensation structure: CFO Tracy Farr discussed steps to modernize and centralize corporate functions, aiming to decouple expense growth from revenue growth. The company is also reviewing its compensation deferral practices to accelerate expense recognition and improve transparency, which could result in a temporary increase in the reported comp ratio but lower it in subsequent years.
• AI adoption and operational leverage: Management highlighted ongoing investment in artificial intelligence to drive productivity in both advisory and asset management. Initiatives include agentic workflows for client servicing and reporting, with an expectation that AI will help reduce expenses and improve margins over time.

Drivers of future performance

Lazard’s outlook is shaped by expectations for continued growth in advisory and asset management, integration of new businesses, and operational efficiency efforts.

• Private capital platform integration: The Campbell Lutyens deal is expected to expand Lazard’s private capital advisory presence, with management projecting approximately $500 million in revenue and earnings accretion in 2027. Early signs of operational and revenue synergies suggest potential for cross-referrals between M&A and fundraising.
• Expense management and margin focus: The firm is pursuing centralization of corporate functions, vendor rationalization, and accelerated compensation expense recognition. Management expects these initiatives to decouple expense from revenue growth, leading to improved margins beginning in 2027, although the impact of compensation changes may cause near-term fluctuations in reported ratios.
• Asset management product innovation: Lazard is scaling its ETF platform and introducing actively managed fixed income ETFs, targeting client demand for differentiated investment strategies. Management believes continued product launches, coupled with strong investment performance, will support net inflows and revenue diversification, though market volatility and private equity deal activity remain risks.

Catalysts in upcoming quarters

Looking ahead, the StockStory team will be watching (1) the operational integration and revenue contribution from the Campbell Lutyens acquisition and launch of Lazard CL, (2) the pace of efficiency gains from corporate function centralization and AI-driven productivity initiatives, and (3) the continued expansion of asset management product offerings, particularly in ETFs and fixed income. Key milestones in private capital advisory and sustained improvement in investment performance will also be important markers of execution.

Lazard currently trades at $37.41, in line with $37.37 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

Our favorite stocks right now

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.